Valeant Providing Reporters With an Earnings Metric the SEC Ordered it to Stop Using Post author:Sam Post published:November 9, 2017 Post category:BioPharma Valeant is not the only company to recently push reporters to defy the SEC’s orders. Source: BioSpace You Might Also Like MilliporeSigma Introduces Next-Generation High-Sensitivity Protein Detection Platform April 2, 2017 Janssen to Terminate Simeprevir License With Medivir, Effective June 2018 December 10, 2017 United Therapeutics Shares Surge on Report of Bids for Company August 3, 2017
